H-DRAHYNI-OH

Ref. 3D-PP45344

Informations sur le produit

• Nom: H-DRAHYNI-OH
• Synonymes: NH2-Asp-Arg-Ala-His-Tyr-Asn-Ile-OH

Description

Peptide H-DRAHYNI-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-DRAHYNI-OH include the following: Polymeric nanoparticles for co-delivery of synthetic long peptide antigen and poly IC as therapeutic cancer vaccine formulation S Rahimian , MF Fransen, JW Kleinovink - Journal of controlled , 2015 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365915000966 A vaccine conjugate of 'ISCAR'immunocarrier and peptide epitopes of the E7 cervical cancer-associated protein of human papillomavirus type 16 elicits specific Th1 RW Tindle , S Croft, K Herd, K Malcolm - Clinical & , 1995 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2249.1995.tb08349.x Chimeric hepatitis B core antigen particles containing B-and Th-epitopes of human papillomavirus type 16 E7 protein induce specific antibody and T-helper responses RW Tindle , K Herd, P Londo, GJP Fernando - Virology, 1994 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0042682284712177 A" public" T-helper epitope of the E7 transforming protein of human papillomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer RW Tindle , GJ Fernando - Proceedings of the , 1991 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.88.13.5887 A helper T-cell epitope of the E7 protein of human papillomavirus type 16 in BALB/c mice RJ Vandebriel , M van der Kolk, L Geerse - Virus research, 1995 - Elsevierhttps://www.sciencedirect.com/science/article/pii/016817029500016J T-helper epitopes identified within the E6 transforming protein of cervical cancer-associated human papillomavirus type 16 R Azoury-Ziadeh, K Herd, GJP Fernando - Viral , 1999 - liebertpub.comhttps://www.liebertpub.com/doi/abs/10.1089/vim.1999.12.297 T cell responses to the human papillomavirus type 16 E7 protein in mice of different haplotypes PS Shepherd, TTT Tran, AJ Rowe - Journal of General , 1992 - microbiologyresearch.orghttps://www.microbiologyresearch.org/content/journal/jgv/10.1099/0022-1317-73-5-1269 Fine Characterization of the HPVI6 E7 49-57 Tumor Protective Cytotoxic T Cell Epitope"Rahynivtf" MCW Feltkamp , MPM Vierboom , J ter Schegget - Immunology of human , 1994 - Springerhttps://link.springer.com/chapter/10.1007/978-1-4615-2449-6_43 Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells MCW Feltkamp , HL Smits - European journal of , 1993 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.1830230929 Presentation of the HPV16E7 protein by skin grafts is insufficient to allow graft rejection in an E7-primed animal LA Dunn, M Evander , RW Tindle , AL Bulloch - Virology, 1997 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0042682297986505 Delivered antigen peptides to resident CD8alpha+ DCs in lymph node by micelle-based vaccine augment antigen-specific CD8+ effector T cell response L Wang, Z Wang, Y Qin, W Liang - European Journal of Pharmaceutics and , 2020 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0939641119313244 Immunogenicity of dendritic cell-based HPV16 E6/E7 peptide vaccines: CTL activation and protective effects J Velek - Folia Biologica (Praha), 2004 - ulm.lf1.cuni.czhttp://ulm.lf1.cuni.cz/Data/files/Folia%20Biologica/Volume%2050%20(2004)%20No.%206/2004-50-184-193.pdf Pathophysiologic aspects of human papillomavirus infection J Paavonen - Current Opinion in Infectious Diseases, 1993 - journals.lww.comhttps://journals.lww.com/co-infectiousdiseases/abstract/1993/02000/pathophysiologic_aspects_of_human_papillomavirus.6.aspx VacaÂœvoj terapeuticke vakcaca­ny proti nadorà ¯m vyvolanacaÂœm lidskacaÂœm papilomavirem 16-vliv modifikace antigenu E7 na buněčnou imunitnaca­ odpovÄ›d J Mackova - 2007 - dspace.cuni.czhttps://dspace.cuni.cz/handle/20.500.11956/102366 Tolerance or immunity to a tumor antigen expressed in somatic cells can be determined by systemic proinflammatory signals at the time of first antigen exposure IH Frazer , RD Kluyver, GR Leggatt - The Journal of , 2001 - journals.aai.orghttps://journals.aai.org/jimmunol/article/167/11/6180/70492 Synthesis and biological evaluation of a lipopeptide-based methamphetamine vaccine F Liao, H Wang, Y Dao, K Yuan, J Lu, J Shi - Chinese Chemical , 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1001841720306215 Intranasal delivery of Salmonella OMVs decorated with Chlamydia trachomatis antigens induces specific local and systemic immune responses DT Huynh , E Nolfi, L Medfai, P van Ulsen - Human Vaccines & , 2024 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/21645515.2024.2330768 Computer-assisted analysis of molecular mimicry between human papillomavirus 16 E7 oncoprotein and human protein sequences C Natale, T Giannini, A Lucchese - Immunology and cell , 2000 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1046/j.1440-1711.2000.00949.x

• Marque: Biosynth